ABP Company Profile and Key Details

NASDAQ : ABP

Abpro

$0.52

Open: 4:00 PM

Not Actively Trading

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Abpro Corporation (ABP) stock remained unchanged at $0.52 a share on NASDAQ. The stock opened at $0.76, fluctuating between $0.52 to $0.76 during the session.

Stock Snapshot

0.522

Prev. Close

1.06M

Market Cap

0.522

Day Low

-0.06327272727272727

P/E Ratio

-8.25

EPS (TTM)

N/A

Cash Flow per Share

0.76

Open

2.03M

Number of Shares

0.759

Day High

54.11%

Free Float in %

N/A

Book Value

1.33M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 09, 2026	0.76	0.76	0.52	0.52	1.33M
Mar 02, 2026	0.76	0.76	0.52	0.52	1.33M
Feb 20, 2026	0.76	0.78	0.52	0.52	1.59M
Feb 19, 2026	0.58	0.88	0.56	0.80	2.81M
Feb 18, 2026	0.60	0.61	0.54	0.58	286.16K
Feb 17, 2026	0.75	0.76	0.58	0.60	482.03K
Feb 13, 2026	0.81	0.88	0.70	0.74	436.6K
Feb 12, 2026	1.13	1.20	0.80	0.83	1.53M
Feb 11, 2026	1.26	1.32	1.12	1.27	2.6M
Feb 10, 2026	2.56	2.89	1.65	1.67	73.94M
Feb 09, 2026	1.52	1.70	1.51	1.52	1.07M
Feb 06, 2026	1.49	1.55	1.46	1.50	23.56K
Feb 05, 2026	1.80	1.80	1.44	1.50	63.65K
Feb 04, 2026	1.90	1.90	1.79	1.86	14.96K
Feb 03, 2026	2.04	2.16	1.90	1.90	15.52K
Feb 02, 2026	1.96	2.00	1.90	1.92	30.11K
Jan 30, 2026	1.90	2.20	1.80	1.93	34.74K
Jan 29, 2026	2.35	2.50	1.94	1.95	61.73K
Jan 28, 2026	2.08	2.90	2.06	2.35	284.17K
Jan 27, 2026	2.31	2.31	2.00	2.02	25.31K

Contact Details

Woburn, MA 01801

United States

https://abpro.com 617 225 0808

About Company

Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-100, designed to target breast, gastric, and colorectal cancers, and ABP-201, intended for the treatment of vascular diseases affecting the eye. The company has established strategic alliances with Abpro Bio Co. Ltd and NJCTTQ. Originally known as Abpro Corporation, the company officially changed its name to Abpro Holdings, Inc. in November 2024. Incorporated in 2004, Abpro Holdings, Inc. operates from its headquarters in Woburn, Massachusetts.

Stock Peers

ARGX

28.55+3.37%

argenx SE$874.74 REGN

3.04+0.45%

Regeneron Pharmaceuticals, Inc.$675.19 MDGL

11.1+2.07%

Madrigal Pharmaceuticals, Inc.$546.79 UTHR

6.49+1.23%

United Therapeutics Corporation$535.83 VRTX

1.5+0.31%

Vertex Pharmaceuticals Incorporated$482.00 KRYS

-0.16-0.05%

Krystal Biotech, Inc.$339.06 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ONC

8.11+2.61%

BeOne Medicines AG$318.69 PRAX

13.44+4.41%

Praxis Precision Medicines, Inc.$317.87 LGND

11.48+3.90%

Ligand Pharmaceuticals Incorporated$305.47

Company Overview

The stock is currently mid-range between its 52-week high and low $0.11 and $18.03. With a market capitalization of about $1.06 million, Abpro Corporation is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.00). Key stats such as the average daily volume over the past year has been around 1.72 million shares, in line with its 52-week average. Headquartered in Woburn, MA, Abpro Corporation operates in the Healthcare sector and the Biotechnology industry. Led by CEO Jin Wook Suk, the company employs approximately 6 people and listed since March 09, 2022. Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity.

Technical Performance

ABP has shown weak momentum, losing -21.17% over the past week and -45.68% over the past quarter, though year-to-date performance is down -26.95%. Short-term trend indicators are bullishly aligned (SMA20 -65.53%, SMA50 -84.13%, SMA200 -90.96%). The stock’s 14-day RSI is 22.04 (weak momentum), while the ATR of 0.37 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -98.26% below its high and over 0.96% above its low.

Valuation Metrics

Abpro Corporation trades at a P/E ratio of -0.11, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of -0.08 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.2, also above market averages.

Dividend & Fair Value

Abpro Corporation last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.08. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Abpro Corporation earnings surprise history is a mixed track record. The quarter that ended November 14, 2025, missed forecasts by -47.5%.

Shareholding & Insider Activity

Abpro Corporation has 2.72 million shares outstanding. The public float is 1.73 million shares, elevated short interest at 1.05% of float. This equals 18.25 thousand shares. The short ratio is 0.58 days. Institutional investors hold 4.52% of the float. Insiders own 34.93%.

Financial & Profitability Overview

Over the trailing twelve months, Abpro has not generated any revenue.
On valuation metrics, Abpro trades at a P/E of -0.11, P/S of 0.00 and P/B of -0.08. Liquidity is tight, with a current ratio of 0.07 and quick ratio of 0.07. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -6071.34 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is -0.01, supported by a cash flow-to-debt ratio of -36.64.

Price Forecast & Outlook

Our AI price prediction model suggests that Abpro Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -100.0%, with price expected at $0.00 by March 23, 2026, within a range of $0.00 to $0.00 3-Month Outlook: Projected rise of 11.11%, reaching $0.58 by June 05, 2026, with a range of $0.00 to $1.61. 1-Year Outlook: Projected gain of 93.49%, with price at $1.01 by March 09, 2027, within a range of $0.00 to $2.44.

Key Takeaways

Abpro Corporation (NASDAQ:ABP) shares are down -26.95% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Abpro Corporation trading at a premium to the broader market with a P/E of -0.11. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $4.00, suggesting 666.28% upside. Our AI forecast model points to short-term weakness (-100.0% over two weeks), a medium-term rise (11.11% over three months), and a longer-term gain (93.49% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Abpro Corporation (ABP) stock price?

Abpro Corporation (NASDAQ: ABP) stock price is $0.52 in the last trading session. During the trading session, ABP stock reached the peak price of $0.76 while $0.52 was the lowest point it dropped to. The percentage change in ABP stock occurred in the recent session was 0% while the dollar amount for the price change in ABP stock was $0.00.

ABP's industry and sector of operation?

The NASDAQ listed ABP is part of Biotechnology industry that operates in the broader Healthcare sector. Abpro Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ABP?

No Data

How ABP did perform over past 52-week?

ABP's closing price is 374.55% higher than its 52-week low of $0.11 where as its distance from 52-week high of $18.03 is -97.11%.

How many employees does ABP have?

Number of ABP employees currently stands at 6.

Link for ABP official website?

Official Website of ABP is: https://abpro.com

How do I contact ABP?

ABP could be contacted at phone 617 225 0808 and can also be accessed through its website. ABP operates from 68 Cummings Park Drive, Woburn, MA 01801, United States.

How many shares of ABP are traded daily?

ABP stock volume for the day was 1.33M shares. The average number of ABP shares traded daily for last 3 months was 1.72M.

What is the market cap of ABP currently?

The market value of ABP currently stands at $1.06M with its latest stock price at $0.52 and 2.03M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	6
Beta	0
Sales or Revenue	N/A
5Y Sales Change%	-0.748%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

ABP Company Profile and Key Details

Abpro

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Shareholding & Insider Activity

Dividend & Fair Value

Key Takeaways

Price Forecast & Outlook

Company Overview

Valuation Metrics